We're Making Our Debut at GIC 2026
Salus has successfully concluded an incredibly productive exhibition at the Genomics India Conference 2026, held in Bangalore cementing its role as a key driver in the precision medicine/oncology and genomics ecosystem. The high-profile event gathered key stakeholders in the genomics and precision medicine ecosystem, including genomics KOLs, oncologists, healthcare professionals, and genomic service providers to discuss the future of targeted therapeutics for treatment decision making.
Representing the company, Dr. Ravi Kumar Chilukoti, Salus' Director for South Asia Business Development & Tech Support, delivered a well-received presentation on precision oncology. His address centered on three core clinical pillars:
1. Advanced Cancer Diagnosis: Leveraging precise genomic insights for early and accurate detection.2. Individualized Treatment Decisions: Tailoring therapies based on the unique genomic alterations of each patient.
3. Enhanced Relapse Monitoring: Utilizing personalized genomic profiling to track post-treatment recurrence with high sensitivity.
Dr. Chilukoti also shared a data-driven comparative analysis of Amoy Diagnostics' Oncology NGS panels, benchmarking their performance across Salus platforms against alternative systems. The presentation demonstrated Salus’ ability to deliver high-performance, reproducible genomic solutions that empower clinical decision-making.
Throughout the conference, the Salus exhibition booth served as a hub for collaborative discussions. Company representatives met with various industry stakeholders and research clinicians to address specific project requirements using Salus' precision oncology and spatial transcriptomics product portfolios.
Thanks to everyone who has joined and participated in our talk session and the KOLs and other participants of conference visited Salus' booth for engaging discussions on their project requirements using our Precision medicine/Oncology product solutions, and spatial transcription solution products.
It was an immense pleasure meeting you all and we thank you for the stimulating conversations!
